Anuncio
Anuncio
ADIL
Adial Pharmaceuticals, Inc
0.24
USDPatrocinado
+0.01
+3.64%
09 ene, 15:41 UTC -5
Cerrado
Post-mercado
0.25
0.00
+1.65%
Informes de beneficios de ADIL
Ratio de Sorpresa Positivo
ADIL superó 13 de las últimas 25 estimaciones.
52%
Próximo informe
Fecha del próximo informe
02 mar 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.08
Cambio implícito desde Q3 25 (Revenue/ EPS)
--
/--
Cambio implícito desde Q4 24 (Revenue/ EPS)
--
/-77.14%
Adial Pharmaceuticals, Inc earnings per share and revenue
On 13 nov 2025, ADIL reported earnings of -0.08 USD per share (EPS) for Q3 25, beating the estimate of -0.14 USD, resulting in a 43.98% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.91% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of -0.08 USD, with revenue projected to reach -- USD, implying an aumentar of 0.00% EPS, and aumentar of 0.00% in Revenue from the last quarter.
Preguntas frecuentes
What were Adial Pharmaceuticals, Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Adial Pharmaceuticals, Inc reported EPS of -$0.08, beating estimates by 43.98%, and revenue of $0.00, 0% as expectations.
How did the market react to Adial Pharmaceuticals, Inc's Q3 2025 earnings?
The stock price moved up 1.91%, changed from $0.32 before the earnings release to $0.33 the day after.
When is Adial Pharmaceuticals, Inc expected to report next?
The next earning report is scheduled for 02 mar 2026.
What are the forecasts for Adial Pharmaceuticals, Inc's next earnings report?
Based on 5
analistas, Adial Pharmaceuticals, Inc is expected to report EPS of -$0.08 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Cheque FXEmpire's Earnings Calendar for today's list of reporting companies.
Anuncio